THIRD QUARTER 2023 FINANCIAL RESULTS ©2023 Vertex Pharmaceuticals Incorporated VERTEX On track to complete Ph3 bunionectomy and single arm safety and effectiveness trial by end of 2023 • Granted Fast Track and Breakthrough Therapy designations ©2023 Vertex Pharmaceuticals Incorporated Each stage can take several months | --- | --- | --- | |-------------------------------------------------------------------------------------|------------------------------------------------------------------------------------ ...